Target therapy for lung cancer Doctors Abroad — Page 2

Prof. Dr. Gül Alço is a radiation oncologist with about 27 years of experience. She treats breast, lung, prostate, gastrointestinal, gynecologic, central nervous system, head and neck, soft tissue, and bone cancers with radiotherapy.

Her expertise includes adaptive radiotherapy and radiosurgery. She uses advanced radiation techniques to provide personalized, evidence-based care in a multidisciplinary, patient-centered setting.

Prof. Dr. Abdullah Sakin is a professor of medical oncology. He treats solid tumors, including lung, breast, gastrointestinal, genitourinary, gynecologic, head and neck cancers, and melanoma.

He delivers personalized, evidence-based care. His treatments include chemotherapy, targeted therapy, immunotherapy, hormone therapy, and precision oncology. He has authored more than 200 scientific publications and takes part in international clinical research. This work advances patient-centered cancer care.

Dr Sridhar P.S. is a specialist radiation oncologist at HCG Manavata Cancer Centre with dual certifications from the National Board of Examinations and Banaras Hindu University.

• Holds a Diplomate of National Board (DNB) in radiotherapy for high-level clinical expertise
• Active member of the Society for Neuro-Oncology focusing on complex tumour cases
• Member of the Association of Radiation Oncology of India
• Focuses on precision-based oncology protocols within the Indian Association of Hyperthermia Oncology

Professor Raj Nagarkar has performed over 50,000 cancer surgeries and leads research as a primary investigator on more than 200 clinical trials.

• Trained in surgical oncology at the Tata Memorial Hospital in Mumbai
• Holds a membership with the Royal College of Surgeons in Edinburgh
• Specialises in thoracic oncology with a focus on lung and chest tumours
• Professor for surgical oncology for the Delhi National Board
• Active in phase 1 to 3 clinical trials for new cancer therapies

Dr Shaunak Valame focuses on the molecular basis of cancer to deliver precise targeted therapies at HCG Manavata Cancer Centre.

• Trained in Medical Oncology at Indraprastha Apollo Hospital in New Delhi
• Presented research to the American Society of Clinical Oncology in San Francisco
• Completed a registrarship at the Jawaharlal Nehru Cancer Hospital and Research Centre
• Specialises in matching specific genetic mutations to modern drug treatments
• Experienced in delivering lectures for international oncology programmes

Professor Lalit Banswal has performed 10,000 major surgeries and specialises in high-precision surgical oncology at the HCG Manavata Cancer Centre.

• Completed a surgical oncology fellowship at the prestigious Tata Medical Centre
• Assistant Professor at the State Cancer Institute training the next generation of oncologists
• Specialises in minimally invasive robotic and laparoscopic techniques for complex tumours
• Served as a lead investigator for clinical research at Tata Medical Center
• Expert in performing delicate resections and complex endoscopic procedures

Dr. Ahmer Arif Shaikh is a surgical oncologist at HCG Manavata Cancer Centre. He specializes in oral cancer treatment with a focus on organ preservation. Dr. Shaikh completed fellowship training in head and neck surgical oncology at the same center. He is proficient in performing major maxillofacial and head and neck surgeries.

• Expert in functional rehabilitation for patients recovering from oral cancer.
• Active researcher with multiple publications in various medical journals.
• Works at an NABH-accredited center that treats over 75,000 patients yearly.
• Treats complex conditions including tongue, thyroid, and tonsil cancers.

Dr Shruti Kate was the solo Indian recipient of the travel award at the 2018 World Conference on Lung Cancer for her researched insights into the field.

• Head of Department and Consultant at HCG Manavata Cancer Centre
• Former consultant at Tata Memorial Hospital – India's premier cancer research institute
• Uses immunotherapy and metronomic therapy to manage advanced stage lung cancers
• Member of the International Association for the Study of Lung Cancer (IASLC)
• Actively presents clinical research on lung cancer at global conferences like WCLC Toronto